Completed NA INTERVENTIONAL 4-arm NCT03938363

Analysis of Gait Before and After Botulinum Toxin Treatment in Patients With Focal Dystonia (GAIT-TOX)

Analyse de la Marche de Patients Atteints de Dystonie Focale Avant et après Traitement Par Toxine Botulique

Sponsor: University Hospital, Grenoble

Conditions Blepharospasm Cervical Dystonia, Primary

Interventions Botulinum Toxin injection Severity scale of the disease Treadmill

Updated 10 times since 2019 Last updated: Dec 15, 2025 Started: Oct 23, 2019 Primary completion: Jun 13, 2022 Completion: Jun 13, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03938363, this NA trial focuses on Blepharospasm and Cervical Dystonia, Primary and remains completed. Sponsored by University Hospital, Grenoble, it has been updated 10 times since 2019, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Jan 2026 — Present [monthly]

Completed NA
Sep 2024 — Jan 2026 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Feb 2023 — Jul 2024 [monthly]

Completed NA

Status: Recruiting → Completed
Oct 2021 — Feb 2023 [monthly]

Recruiting NA

▶ Show 5 earlier versions

Apr 2021 — Oct 2021 [monthly]

Recruiting NA
Jan 2021 — Apr 2021 [monthly]

Recruiting NA
Apr 2020 — Jan 2021 [monthly]

Recruiting NA
Jan 2020 — Apr 2020 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Jun 2019 — Jan 2020 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University Hospital, Grenoble

Data source: University Hospital, Grenoble

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• La Tronche, France